Walmsley: GSK Is 'Prepared' And 'Ready' For US Advair Generic Launch

 
• By Jessica Merrill

GlaxoSmithKline is poised for a challenging 2018, with an interchangeable Advair generic expected to launch, but GSK believes growth from new products will make up some of the loss. US Advair sales could be slashed to £750m from £1.6bn in 2017.

Young woman wearing in climbing equipment standing in front of a stone rock outdoor and preparing to climb, rear view

More from Earnings

More from Business